Skip to content
2000
Volume 20, Issue 12
  • ISSN: 0929-8665
  • E-ISSN: 1875-5305

Abstract

Short peptides are important biopharmaceuticals as agonistic or antagonistic ligands, aggregation inhibitors, and vaccines, as well as in many other applications. They behave differently from globular proteins in solution. Many short peptides are unstructured and tend to aggregate and undergo structural transition in response to changes in solvent environment, including pH, temperature, ionic strength, presence of organic solvents or surfactants, and exposure to lipid membranes. Such structural transitions are often associated with fibril or β-amyloid formation. These structural characteristics of short peptides have drastic impact on their function, immunogenicity, and storage stability.

Loading

Article metrics loading...

/content/journals/ppl/10.2174/092986652012131112121417
2013-12-01
2025-10-12
Loading full text...

Full text loading...

/content/journals/ppl/10.2174/092986652012131112121417
Loading

  • Article Type:
    Research Article
Keyword(s): aggregation; formulation; membrane; Peptide; structure flexibility; vaccine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test